We’re proud to share that PHSE has won the BSMA Europe Innovation Award 2025 for our project “Precision Logistics for Cell & Gene Therapy – A Risk-Based Operational Model.”
Our Cell & Gene Therapy division has implemented a risk-based, precision-driven logistics model that leverages multimodal solutions to ensure the safe, timely, and fully compliant delivery of advanced therapies across Europe.
Because these therapies are living, high-value, and irreplaceable, our approach guarantees total traceability and zero margin for error at every stage of the logistics process.
We are deeply honored to receive this recognition from BSMA Europe, which highlights our continuous commitment to excellence and innovation.
